Data / Form D filings / Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc.: Form D filings
Avicenna Biosciences, Inc., a biotechnology company in Durham, NC, filed 7 Form D notices with the SEC between 2020 and 2025. The latest, on October 30, 2025, reports $70,650 sold of a $70,650 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 W. CHAPEL HILL STREET, SUITE 210, Durham, NC, 27701
- Phone
- (919) 667-2504
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1824034
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | Amendment | $70,650 | $70,650 | 1 | Feb 17, 2022 | sec.gov | |
| Jul 16, 2024 | New notice | $6,000,000 | $6,000,000 | 1 | Jul 1, 2024 | sec.gov | |
| Feb 23, 2024 | New notice | $10,000,000 | $6,000,000 | $4,000,000 | 1 | Nov 3, 2023 | sec.gov |
| Mar 22, 2023 | Amendment | $41,318 | $27,450 | $13,868 | 1 | Feb 17, 2022 | sec.gov |
| Dec 30, 2022 | New notice | $6,000,000 | $3,000,000 | $3,000,000 | 1 | Apr 15, 2022 | sec.gov |
| Oct 27, 2022 | New notice | $18,000 | $18,000 | 1 | Feb 17, 2022 | sec.gov | |
| Sep 14, 2020 | New notice | $2,500,000 | $2,500,000 | 1 | Aug 28, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pieter Burger | Executive Officer, Director | |
| John Hamer | Director | |
| Dennis Langer | Director | |
| Thomas Kaiser | Executive Officer, Director | |
| Christopher Meldrum | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 27, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avicenna Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.